Corporate Social Responsability

CSR report

Our 2021 Corporate Social Responsibility report

This report formalizes our commitment to a sustainable and ethical approach of our practices in order to meet social and environmental challenges. SGH Medical Pharma’ strategy is based on shared values that are essential to the completion of our daily tasks.

This report illustrates the main actions carried our during the year 2021.

A word from our CEO

« SGH Medical Pharma’s commitment is at a turning point. To reach a high level of coherence between our customers’ and our stakeholders’ expectations, we have made ambitious commitments for the future. Every day, our teams ensure that they are met by building upon their skills and know-how in harmony with the values of the group. »

Jérôme Empereur
CEO SGH Medical Pharma

Jérôme Empereur SGH Medical Pharma

Our commitments

Our approach revolves around 4 main axes:

Making a positive contribution to society

Reducing our impact on the environment

Taking care of our stakeholders

Provide sustainable employment

Making a positive contribution to society


of employees are in apprenticeship contracts


of suppliers in France


of suppliers have signed our Code of Ethics according to our objectives

of suppliers in Europe

Reducing our impact on the environment


new materials tried out

Energy performance indicators :


of recycled plastics


consumed per ton of material used


of recycled cardboard


increase in electric presses


of recycled office waste


of CO2 released thanks to our waste management

Taking care of our stakeholders

well-being at work


hiring rate for permanent employees

Ensuring employee’s health and safety


average well being at work grade

Building a trust relationship with our stakeholders: 1 yearly check


dedicated to training

Provide sustainable employment


of employees trained each year


of employees CSR-conscious

Innovate through

Life Cycle Assessment


of employees trained through the last 3 years

Our acknowledgments

Lucie 26000

Lucie 26000

Our CSR approach, carried out at the highest level of the company, is established for the whole group but is also supported by all employees. This demonstrates the organization’s willingness to integrate social and environmental considerations into its decision-making processes and to be accountable for the impact of its decisions and activities on society and the environment. These actions have been externally audited, which led to the LUCIE 26000 certification.


We are regularly assessed by ECOVADIS, an internationally recognized company, to evaluate our sustainable development performance across the entire company based on 7 CSR criteria. In 2022, we obtained the gold medal in the Medium Size Company category, with a score of 74/100.

Ask for our assessment report

ISO 14001 : 2015 certification

Since 2006, the environmental approach has been at the heart of our concerns. This certification allows us to constantly improve and reduce our negative impact on the environment.
Two sites are certified ISO 14001.

Certificates of conformity to decree n°2021-461 from April 1, 2021

As part of the AGEC law for anti-waste and circular economy and to comply with decree n°2021-461, our manufaturing sites have been audited in order to assess the measures taken to prevent the loss and discharge of industrial plastic compounds into the environment. This approach underlines our commitment to reducing our impact on the environment.

Find our certificates for the Stiplastics, Rovipharm and Eskiss sites (French only).

Our support

SGH Medical Pharma attaches great importance to respecting the laws, regulations and universal ethical principles supported by the Universal Declaration of Human Rights and as described in the 17 UN Sustainable Development Goals, for all our activities around the world. Therefore, we naturally renewed our support to UN Global Compact, as we have done since 2009.

UN global compact